Tristan Peitz
Geen lopende functies
Profiel
Tristan Anthony Peitz worked as a Managing Director at Cohen Capital Management, Inc. (California) from 2010 to 2019.
He also served as an Independent Director at QSAM Biosciences, Inc. from 2017 to 2020.
Peitz received an undergraduate degree from the Stephen M.
Ross School of Business.
Eerdere bekende functies van Tristan Peitz
| Bedrijven | Functie | Einde |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Directeur/Bestuurslid | 09-12-2020 |
Cohen Capital Management, Inc. (California)
 Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Portfolio Manager-Fixed Income | 01-07-2019 |
Opleiding van Tristan Peitz
| Stephen M. Ross School of Business | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cohen Capital Management, Inc. (California)
Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Finance |
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
